Potential of lung surfactant proteins, SP-A and SP-D, and mannan binding lectin for therapy and genetic predisposition to allergic and invasive aspergillosis.

Recent patents on inflammation & allergy drug discovery

Volumn 1, Issue 3, 2007, Pages 183-187

  Madan, Taruna ^a  

^a NATIONAL INSTITUTE FOR RESEARCH IN REPRODUCTIVE HEALTH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; MANNOSE BINDING LECTIN; RECOMBINANT PROTEIN; RESPIRATORY TRACT AGENT; SURFACTANT PROTEIN A; SURFACTANT PROTEIN D;

ANIMAL; ASPERGILLUS FUMIGATUS; GENETIC PREDISPOSITION; GENETICS; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; LUNG ASPERGILLOSIS; MICROBIOLOGY; PATENT; REVIEW; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; ANTIFUNGAL AGENTS; ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY; ASPERGILLUS FUMIGATUS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNITY, INNATE; INVASIVE PULMONARY ASPERGILLOSIS; MANNOSE-BINDING LECTIN; PATENTS AS TOPIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; RECOMBINANT PROTEINS; RESPIRATORY SYSTEM AGENTS; RISK FACTORS;

EID: 60849104464     PISSN: 1872213X     EISSN: None     Source Type: Journal    
DOI: 10.2174/187221307782418874     Document Type: Review

References (36)